Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 1,109.7 | 320.8 | 79.3 | 0.0 |
| Revenue growth | 245.9% | 304.7% | | |
| Cost of goods sold | 1,096.2 | 372.6 | 105.1 | 0.0 |
| Gross profit | 13.5 | -51.8 | -25.8 | 0.0 |
| Gross margin | 1.2% | -16.1% | -32.6% | |
| Selling, general and administrative | 227.9 | 187.2 | 90.7 | 0.0 |
| Research and development | 79.2 | 68.5 | 80.5 | |
| EBITA | -301.2 | -308.5 | -202.1 | 0.0 |
| EBITA margin | -27.1% | -96.1% | -255.0% | |
| Amortization of intangibles | 4.5 | 7.6 | | |
| EBIT | -305.7 | -316.1 | -202.1 | 0.0 |
| EBIT margin | -27.5% | -98.5% | -255.0% | |
| Pre-tax income | -221.5 | -84.9 | -208.4 | 0.0 |
| Income taxes | -0.1 | -1.4 | 4.6 | 0.0 |
| Tax rate | 0.0% | 1.7% | | |
| Net income | -221.4 | -77.4 | -211.8 | 0.0 |
| Net margin | -20.0% | -24.1% | -267.2% | |
| |
| Diluted EPS | ($12.01) | ($6.93) | ($21.80) | |
| Shares outstanding (diluted) | 18.4 | 11.2 | 9.7 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|